Becton Dickinson and Stock Price, News & Analysis (NYSE:BDX)

$231.37 2.83 (1.24 %)
(As of 01/18/2018 02:40 AM ET)
Previous Close$228.54
Today's Range$226.74 - $231.38
52-Week Range$169.19 - $231.38
Volume1.67 million shs
Average Volume1.68 million shs
Market Capitalization$53.08 billion
P/E Ratio49.76
Dividend Yield1.32%
Beta1.07

About Becton Dickinson and (NYSE:BDX)

Becton Dickinson and logoBecton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Receive BDX News and Ratings via Email

Sign-up to receive the latest news and ratings for BDX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Supplies
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNYSE:BDX
CUSIP07588710
Phone+1-201-8476800

Debt

Debt-to-Equity Ratio1.44%
Current Ratio5.58%
Quick Ratio5.03%

Price-To-Earnings

Trailing P/E Ratio49.7569892473118
Forward P/E Ratio21.70
P/E Growth1.78

Sales & Book Value

Annual Sales$12.09 billion
Price / Sales5.10
Cash Flow$14.33 per share
Price / Cash16.15
Book Value$56.89 per share
Price / Book4.07

Profitability

Trailing EPS$4.65
Net Income$1.10 billion
Net Margins8.52%
Return on Equity20.56%
Return on Assets6.85%

Miscellaneous

Employees41,933
Outstanding Shares266,420,000

Becton Dickinson and (NYSE:BDX) Frequently Asked Questions

What is Becton Dickinson and's stock symbol?

Becton Dickinson and trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton Dickinson and pay dividends? What is the dividend yield for Becton Dickinson and?

Becton Dickinson and announced a quarterly dividend on Monday, November 20th. Investors of record on Friday, December 8th will be paid a dividend of $0.75 per share on Friday, December 29th. This represents a $3.00 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date is Thursday, December 7th. This is a boost from Becton Dickinson and's previous quarterly dividend of $0.73. View Becton Dickinson and's Dividend History.

How were Becton Dickinson and's earnings last quarter?

Becton Dickinson and Co (NYSE:BDX) issued its earnings results on Thursday, November, 2nd. The medical instruments supplier reported $2.40 earnings per share for the quarter, topping analysts' consensus estimates of $2.37 by $0.03. The medical instruments supplier earned $3.17 billion during the quarter, compared to analyst estimates of $3.14 billion. Becton Dickinson and had a net margin of 8.52% and a return on equity of 20.56%. The company's revenue was down 2.0% compared to the same quarter last year. During the same period in the previous year, the business earned $2.12 earnings per share. View Becton Dickinson and's Earnings History.

When will Becton Dickinson and make its next earnings announcement?

Becton Dickinson and is scheduled to release their next quarterly earnings announcement on Tuesday, February, 6th 2018. View Earnings Estimates for Becton Dickinson and.

What guidance has Becton Dickinson and issued on next quarter's earnings?

Becton Dickinson and issued an update on its FY18 earnings guidance on Thursday, November, 2nd. The company provided earnings per share (EPS) guidance of 10.55-10.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $10.41.

Where is Becton Dickinson and's stock going? Where will Becton Dickinson and's stock price be in 2018?

15 brokers have issued 12-month price targets for Becton Dickinson and's stock. Their predictions range from $180.00 to $260.00. On average, they expect Becton Dickinson and's stock price to reach $229.50 in the next year. View Analyst Ratings for Becton Dickinson and.

Who are some of Becton Dickinson and's key competitors?

Who are Becton Dickinson and's key executives?

Becton Dickinson and's management team includes the folowing people:

  • Vincent A. Forlenza, Chairman of the Board, Chief Executive Officer (Age 64)
  • Thomas E. Polen, President (Age 44)
  • Christopher R. Reidy, Chief Financial Officer, Executive Vice President, Chief Administrative Officer (Age 60)
  • Linda M. Tharby, Chief Human Resource Officer, Executive Vice President (Age 49)
  • Nabil Shabshab, Executive Vice President - Strategic Planning Chief Marketing Officer (Age 52)
  • Alexandre Conroy, Executive Vice President and President, Europe, EMA (Age 54)
  • James Lim, Executive Vice President and President, Greater Asia (Age 53)
  • Alberto Mas, Executive Vice President and President - Life Sciences Segment (Age 56)
  • Basil L. Anderson, Independent Director (Age 71)
  • Catherine M. Burzik, Independent Director (Age 67)

Who owns Becton Dickinson and stock?

Becton Dickinson and's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Schwab Charles Investment Management Inc. (0.36%), Waverton Investment Management Ltd (0.16%), Bank of Montreal Can (0.16%), Bristol John W & Co. Inc. NY (0.11%), National Pension Service (0.09%) and Atalanta Sosnoff Capital LLC (0.08%). Company insiders that own Becton Dickinson and stock include Ellen R Strahlman, Gary M Cohen, James C Lim, James F Orr, Jeffrey S Sherman, Jerome V Hurwitz, John E Gallagher, Linda M Tharby, Nabil Shabshab, Rebecca W Rimel, Ribo Alberto Mas, Stephen Sichak, Thomas E Polen Jr and Vincent A Forlenza. View Institutional Ownership Trends for Becton Dickinson and.

Who sold Becton Dickinson and stock? Who is selling Becton Dickinson and stock?

Becton Dickinson and's stock was sold by a variety of institutional investors in the last quarter, including Vontobel Asset Management Inc., Sit Investment Associates Inc., Bristol John W & Co. Inc. NY, AMI Asset Management Corp, Exxonmobil Investment Management Inc. TX, Atalanta Sosnoff Capital LLC, Gillespie Robinson & Grimm Inc. and First National Bank of Mount Dora Trust Investment Services. Company insiders that have sold Becton Dickinson and company stock in the last year include Ellen R Strahlman, Gary M Cohen, Jeffrey S Sherman, Linda M Tharby, Nabil Shabshab, Ribo Alberto Mas, Stephen Sichak and Thomas E Polen Jr. View Insider Buying and Selling for Becton Dickinson and.

Who bought Becton Dickinson and stock? Who is buying Becton Dickinson and stock?

Becton Dickinson and's stock was bought by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc., Bank of Montreal Can, National Pension Service, Waverton Investment Management Ltd, Nisa Investment Advisors LLC, Gulf International Bank UK Ltd, Davis R M Inc. and Koshinski Asset Management Inc.. View Insider Buying and Selling for Becton Dickinson and.

How do I buy Becton Dickinson and stock?

Shares of Becton Dickinson and can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Becton Dickinson and's stock price today?

One share of Becton Dickinson and stock can currently be purchased for approximately $231.37.

How big of a company is Becton Dickinson and?

Becton Dickinson and has a market capitalization of $53.08 billion and generates $12.09 billion in revenue each year. The medical instruments supplier earns $1.10 billion in net income (profit) each year or $4.65 on an earnings per share basis. Becton Dickinson and employs 41,933 workers across the globe.

How can I contact Becton Dickinson and?

Becton Dickinson and's mailing address is 1 Becton Dr, FRANKLIN LAKES, NJ 07417-1815, United States. The medical instruments supplier can be reached via phone at +1-201-8476800.


MarketBeat Community Rating for Becton Dickinson and (BDX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  323 (Vote Outperform)
Underperform Votes:  426 (Vote Underperform)
Total Votes:  749
MarketBeat's community ratings are surveys of what our community members think about Becton Dickinson and and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Becton Dickinson and (NYSE:BDX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.772.792.64
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
1 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $229.50$217.15$199.54$191.91
Price Target Upside: 3.85% upside0.82% downside4.16% upside5.62% downside

Becton Dickinson and (NYSE:BDX) Consensus Price Target History

Price Target History for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and (NYSE:BDX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/5/2018CitigroupUpgradeSell -> NeutralLowView Rating Details
1/5/2018KeyCorpInitiated CoverageOverweight -> Overweight$260.00LowView Rating Details
1/3/2018Evercore ISIInitiated CoverageOutperform -> Outperform$245.00MediumView Rating Details
12/29/2017Deutsche BankSet Price TargetBuy -> Buy$239.00 -> $260.00LowView Rating Details
12/14/2017ArgusBoost Price TargetAverage -> Buy$235.00LowView Rating Details
11/3/2017Stifel NicolausReiterated RatingBuy$245.00N/AView Rating Details
11/3/2017Morgan StanleyBoost Price TargetEqual Weight$205.00 -> $245.00N/AView Rating Details
11/3/2017Royal Bank of CanadaReiterated RatingSector Perform -> Sector Perform$210.00 -> $230.00N/AView Rating Details
10/24/2017Wells Fargo & CoReiterated RatingOutperform -> Positive$225.00 -> $235.00N/AView Rating Details
9/12/2017Piper Jaffray CompaniesReiterated RatingBuy$213.00HighView Rating Details
8/14/2017CowenReiterated RatingBuy$230.00LowView Rating Details
8/10/2017BarclaysReiterated RatingEqual Weight$205.00 -> $210.00LowView Rating Details
7/21/2017Bank of AmericaReiterated RatingBuy$200.00 -> $225.00MediumView Rating Details
6/30/2017Raymond James FinancialUpgradeOutperform -> Strong-Buy$210.00 -> $180.00LowView Rating Details
3/29/2017Jefferies GroupReiterated RatingBuy$200.00LowView Rating Details
1/3/2017JPMorgan Chase & Co.DowngradeOverweight -> Neutral$190.00 -> $175.00N/AView Rating Details
11/21/2016Leerink SwannReiterated RatingMarket Perform$180.00 -> $185.00N/AView Rating Details
4/8/2016Goldman Sachs GroupBoost Price Target$156.00 -> $157.00N/AView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Becton Dickinson and (NYSE:BDX) Earnings History and Estimates Chart

Earnings by Quarter for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and (NYSE BDX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2018N/AView Earnings Details
11/2/2017Q4 2017$2.37$2.40$3.14 billion$3.17 billionViewN/AView Earnings Details
8/3/2017Q3 2017$2.44$2.46$3.06 billion$3.04 billionViewListenView Earnings Details
5/2/2017Q2 2017$2.23$2.30$2.92 billion$2.97 billionViewListenView Earnings Details
2/2/2017Q117$2.11$2.33$2.86 billion$2.92 billionViewListenView Earnings Details
11/3/2016Q416$2.09$2.12$3.22 billion$3.23 billionViewListenView Earnings Details
8/4/2016Q316$2.20$2.35$3.21 billion$3.20 billionViewListenView Earnings Details
5/5/2016Q216$2.02$2.18$3.07 billion$3.07 billionViewListenView Earnings Details
2/3/2016Q116$1.84$1.96$3.04 billion$2.99 billionViewListenView Earnings Details
11/4/2015Q415$1.90$1.94$3.04 billion$3.07 billionViewListenView Earnings Details
8/6/2015Q315$2.01$2.05$3.13 billion$3.12 billionViewListenView Earnings Details
5/7/2015Q2$1.54$1.61$2.05 billion$2.05 billionViewListenView Earnings Details
2/5/2015Q115$1.43$1.53$2.04 billion$2.05 billionViewListenView Earnings Details
11/4/2014Q414$1.65$1.68$2.16 billion$2.20 billionViewListenView Earnings Details
7/31/2014Q314$1.68$1.68$2.14 billion$2.16 billionViewListenView Earnings Details
5/1/2014Q2$1.50$1.53$2.09 billion$2.07 billionViewListenView Earnings Details
2/4/2014Q114$1.30$1.42$1.98 billion$2.00 billionViewListenView Earnings Details
11/5/2013Q413$1.46$1.52$2.05 billion$2.10 billionViewListenView Earnings Details
8/1/2013Q3 2013$1.48$1.58$2.05 million$2.05 billionViewListenView Earnings Details
5/2/2013Q2 2013$1.35$1.44$1.99 billion$2.00 billionViewListenView Earnings Details
2/5/2013Q1 2013$1.24$1.35$1.86 billion$1.90 billionViewListenView Earnings Details
11/7/2012Q412$1.40$1.42$1.96 billion$1.97 billionViewN/AView Earnings Details
8/2/2012$1.53$1.52ViewN/AView Earnings Details
5/1/2012$1.38$1.38ViewN/AView Earnings Details
2/7/2012$1.17$1.21ViewN/AView Earnings Details
11/2/2011$1.41$1.39ViewN/AView Earnings Details
8/2/2011$1.43$1.53ViewN/AView Earnings Details
4/26/2011$1.30$1.38ViewN/AView Earnings Details
2/7/2011$1.29$1.35ViewN/AView Earnings Details
11/3/2010Q4 2010$1.25$1.24ViewN/AView Earnings Details
7/29/2010Q3 2010$1.25$1.29ViewN/AView Earnings Details
4/29/2010Q2 2010$1.23$1.24ViewN/AView Earnings Details
1/28/2010Q1 2010$1.20$1.30ViewN/AView Earnings Details
11/4/2009Q4 2009$1.24$1.25ViewN/AView Earnings Details
7/30/2009Q3 2009$1.24$1.30ViewN/AView Earnings Details
4/28/2009Q2 2009$1.16$1.18ViewN/AView Earnings Details
1/27/2009Q1 2009$1.16$1.26ViewN/AView Earnings Details
11/5/2008Q4 2008$1.12$1.13ViewN/AView Earnings Details
7/24/2008Q3 2008$1.10$1.18ViewN/AView Earnings Details
4/23/2008Q2 2008$1.04$1.09ViewN/AView Earnings Details
1/24/2008Q1 2008$1.03$1.07ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Becton Dickinson and (NYSE:BDX) Earnings Estimates

2018 EPS Consensus Estimate: $10.23
2019 EPS Consensus Estimate: $12.50
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$2.28$2.28$2.28
Q2 20181$2.42$2.42$2.42
Q3 20181$2.81$2.81$2.81
Q4 20181$2.72$2.72$2.72
Q1 20191$3.04$3.04$3.04
Q2 20191$2.96$2.96$2.96
Q3 20191$3.25$3.25$3.25
Q4 20191$3.25$3.25$3.25
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Becton Dickinson and (NYSE:BDX) Dividend Information

Most Recent Dividend:12/29/2017
Annual Dividend:$3.00
Dividend Yield:1.30%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:64.52% (Trailing 12 Months of Earnings)
28.14% (Based on This Year's Estimates)
23.79% (Based on Next Year's Estimates)
Track Record:46 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and (NYSE:BDX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/20/2017quarterly$0.751.32%12/7/201712/8/201712/29/2017
7/25/2017quarterly$0.731.44%9/7/20179/8/20179/29/2017
5/23/2017quarterly$0.731.56%6/7/20176/9/20176/30/2017
1/23/2017quarterly$0.731.71%3/8/20173/10/20173/31/2017
11/21/2016quarterly$0.731.74%12/7/201612/9/201612/30/2016
7/26/2016quarterly$0.661.51%9/7/20169/9/20169/30/2016
5/24/2016quarterly$0.661.58%6/7/20166/9/20166/30/2016
1/25/2016quarterly$0.661.81%3/8/20163/10/20163/31/2016
11/23/2015quarterly$0.661.75%12/8/201512/10/201512/31/2015
7/28/2015quarterly$0.601.58%9/4/20159/9/20159/30/2015
5/19/2015quarterly$0.601.69%6/5/20156/9/20156/30/2015
1/27/2015quarterly$0.601.65%3/6/20153/10/20153/31/2015
11/25/2014quarterly$0.601.7%12/8/201412/10/201412/31/2014
7/22/2014quarterly$0.551.84%9/5/20149/9/20149/30/2014
5/20/2014quarterly$0.551.88%6/5/20146/9/20146/30/2014
1/28/2014quarterly$0.552.02%3/6/20143/10/20143/31/2014
11/26/2013quarterly$0.552%12/6/201312/10/201312/31/2013
7/23/2013quarterly$0.501.91%9/5/20139/9/20139/30/2013
5/21/2013quarterly$0.501.98%6/5/20136/7/20136/28/2013
1/29/2013quarterly$0.502.35%3/6/20133/8/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

Becton Dickinson and (NYSE BDX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.00%
Institutional Ownership Percentage: 75.54%
Insider Trades by Quarter for Becton Dickinson and (NYSE:BDX)
Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Becton Dickinson and (NYSE BDX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/11/2017Gary M CohenInsiderSell15,512$203.77$3,160,880.2495,781View SEC Filing  
9/8/2017Stephen SichakInsiderSell11,787$200.46$2,362,822.0214,038View SEC Filing  
8/22/2017Gary M CohenInsiderSell15,044$200.43$3,015,268.9295,270View SEC Filing  
8/22/2017Linda M TharbyEVPSell4,695$200.48$941,253.6018,670View SEC Filing  
8/15/2017Nabil ShabshabInsiderSell6,149$201.76$1,240,622.2415,648View SEC Filing  
8/14/2017Ribo Alberto MasEVPSell7,463$201.41$1,503,122.8329,323View SEC Filing  
8/10/2017Ellen R StrahlmanInsiderSell9,283$198.21$1,839,983.4326,638View SEC Filing  
8/9/2017Thomas E Polen JrInsiderSell5,971$197.41$1,178,735.1112,861View SEC Filing  
5/25/2017Jeffrey S ShermanVPSell28,765$185.98$5,349,714.7070,821View SEC Filing  
2/15/2017Jeffrey S ShermanVPSell31,464$180.02$5,664,149.2822,094View SEC Filing  
12/15/2016John E GallagherVPSell1,793$168.82$302,694.262,796View SEC Filing  
12/5/2016Stephen SichakInsiderSell2,632$164.44$432,806.087,953View SEC Filing  
11/4/2016Stephen SichakInsiderSell10,352$176.10$1,822,987.2026,892View SEC Filing  
9/6/2016Linda M TharbyInsiderSell11,704$177.27$2,074,768.0822,146View SEC Filing  
8/11/2016Gary M CohenInsiderSell29,367$176.81$5,192,379.27125,870View SEC Filing  
6/13/2016John E GallagherVPSell1,931$169.87$328,018.976,758View SEC Filing  
6/7/2016Nabil ShabshabEVPSell5,080$168.75$857,250.0011,092View SEC Filing  
5/17/2016Jeffrey S ShermanVPSell34,373$166.27$5,715,198.7149,736View SEC Filing  
5/13/2016Stephen SichakEVPSell12,995$166.48$2,163,407.6031,561View SEC Filing  
5/13/2016Vincent A ForlenzaCEOSell37,933$166.17$6,303,326.61207,225View SEC Filing  
5/10/2016James F OrrDirectorSell1,368$167.66$229,358.8823,045View SEC Filing  
5/9/2016James C LimEVPSell5,257$165.60$870,559.2012,556View SEC Filing  
5/6/2016Ellen R StrahlmanSVPSell3,019$163.52$493,666.887,218View SEC Filing  
5/6/2016Jerome V HurwitzEVPSell3,878$163.58$634,363.243,027View SEC Filing  
5/6/2016Rebecca W RimelDirectorSell684$163.69$111,963.966,835View SEC Filing  
12/14/2015Stephen SichakEVPSell8,670$152.21$1,319,660.708,646View SEC Filing  
12/9/2015William A KozyEVPSell15,495$154.43$2,392,892.8568,823View SEC Filing  
12/8/2015Vincent A. ForlenzaCEOSell17,762$153.10$2,719,362.20172,681View SEC Filing  
12/7/2015Jeffrey S ShermanVPSell7,586$153.76$1,166,423.3623,734View SEC Filing  
12/1/2015Thomas E Polen JrEVPSell2,683$152.21$408,379.435,789View SEC Filing  
11/30/2015John E GallagherVPSell1,600$150.70$241,120.003,393View SEC Filing  
11/18/2015Jerome V. HurwitzEVPSell2,347$151.02$354,443.944,866View SEC Filing  
6/1/2015Stephen SichakEVPSell12,188$140.94$1,717,776.72View SEC Filing  
5/22/2015Thomas E Polen JrEVPSell3,882$142.56$553,417.92View SEC Filing  
5/21/2015Linda M TharbyEVPSell6,069$142.02$861,919.38View SEC Filing  
5/20/2015William A KozyEVPSell10,326$142.00$1,466,292.00View SEC Filing  
5/19/2015William A KozyEVPSell10,435$142.01$1,481,874.35View SEC Filing  
5/18/2015Bertram L ScottDirectorSell2,160$141.74$306,158.40View SEC Filing  
5/18/2015James C LimEVPSell3,604$141.80$511,047.20View SEC Filing  
5/15/2015Alexandre ConroyEVPSell1,291$141.37$182,508.67View SEC Filing  
5/13/2015Jeffrey S ShermanVPSell10,983$138.40$1,520,047.20View SEC Filing  
5/11/2015Jerome V HurwitzEVPSell1,197$141.43$169,291.71View SEC Filing  
5/8/2015Gary M CohenEVPSell13,490$142.90$1,927,721.00View SEC Filing  
6/12/2014Stephen SichakSVPSell1,456$118.25$172,172.00View SEC Filing  
6/10/2014Gary M CohenEVPSell12,476$119.24$1,487,638.24View SEC Filing  
6/9/2014Jeffrey S ShermanVPSell7,877$120.24$947,130.48View SEC Filing  
3/6/2014Jeffrey ShermanVPSell1,303$115.16$150,053.4827,768View SEC Filing  
11/12/2013William KozyEVPSell9,597$108.30$1,039,355.10101,090View SEC Filing  
11/11/2013Jeffrey ShermanVPSell4,272$107.78$460,436.1625,176View SEC Filing  
11/11/2013Jerome HurwitzSVPSell1,151$107.78$124,054.781,687View SEC Filing  
11/8/2013Vincent ForlenzaCEOSell32,411$107.39$3,480,617.29108,724View SEC Filing  
11/6/2013Henry Becton, Jr.DirectorSell2,276$106.77$243,008.5223,820View SEC Filing  
8/23/2013Bertram ScottDirectorSell4,047$98.61$399,074.6720,768View SEC Filing  
8/8/2013Edward DegraanDirectorSell4,436$100.03$443,733.0818,608View SEC Filing  
8/8/2013Stephen SichakSVPSell3,431$100.13$343,546.036,297View SEC Filing  
8/7/2013Basil AndersonDirectorSell2,160$99.79$215,546.4017,221View SEC Filing  
5/22/2013Henry P Becton JrDirectorSell3,117$101.86$317,497.62View SEC Filing  
5/17/2013Donna M BolesVPSell2,415$101.38$244,832.70View SEC Filing  
5/13/2013Gary M CohenEVPSell8,753$100.22$877,225.66View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Becton Dickinson and (NYSE BDX) News Headlines

Source:
DateHeadline
Becton Dickinson and Co (BDX) Receives Average Recommendation of "Buy" from AnalystsBecton Dickinson and Co (BDX) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - January 15 at 7:42 AM
Becton Dickinson says it will provide full response to FDA warning letter by Feb. 1 deadline - MarketWatchBecton Dickinson says it will provide full response to FDA warning letter by Feb. 1 deadline - MarketWatch
www.marketwatch.com - January 14 at 5:46 AM
FDA Confirms Becton Dickinson (BDX) Warning Letter Related to Blood Collection Tubes - StreetInsider.comFDA Confirms Becton Dickinson (BDX) Warning Letter Related to Blood Collection Tubes - StreetInsider.com
www.streetinsider.com - January 13 at 3:16 PM
Becton, Dickinson reverts to older stopper in general-use syringes - Seeking AlphaBecton, Dickinson reverts to older stopper in general-use syringes - Seeking Alpha
seekingalpha.com - January 13 at 6:06 AM
FDA warns 2nd company of significant violations in lead tests - USA TODAYFDA warns 2nd company of 'significant violations' in lead tests - USA TODAY
www.usatoday.com - January 13 at 6:06 AM
Becton Dickinson and (BDX) Downgraded by Zacks Investment ResearchBecton Dickinson and (BDX) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 12 at 3:38 PM
Becton Dickinson says it will provide full response to FDA warning letter by Feb. 1 deadlineBecton Dickinson says it will provide full response to FDA warning letter by Feb. 1 deadline
www.marketwatch.com - January 12 at 3:16 PM
Becton, Dickinson reverts to older stopper in general-use syringesBecton, Dickinson reverts to older stopper in general-use syringes
www.msn.com - January 12 at 3:16 PM
Becton Dickinson (BDX) Issues Statement on FDA Warning Letter for Preanalytical Systems Business UnitBecton Dickinson (BDX) Issues Statement on FDA Warning Letter for Preanalytical Systems Business Unit
www.streetinsider.com - January 12 at 3:16 PM
BD Statement on FDA Warning Letter for Preanalytical Systems Business UnitBD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
finance.yahoo.com - January 12 at 3:16 PM
Becton, Dickinson gets Warning Letter after FDA inspection of New Jersey facility - Seeking AlphaBecton, Dickinson gets Warning Letter after FDA inspection of New Jersey facility - Seeking Alpha
seekingalpha.com - January 12 at 5:51 AM
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference CallBD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
finance.yahoo.com - January 12 at 5:51 AM
FDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issuesFDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issues
www.bizjournals.com - January 11 at 3:17 PM
Stryker’s Stock Rally Continues with 52-Week High YesterdayStryker’s Stock Rally Continues with 52-Week High Yesterday
finance.yahoo.com - January 10 at 3:18 PM
Stryker Announces Preliminary 4Q17 and Fiscal 2017 ResultsStryker Announces Preliminary 4Q17 and Fiscal 2017 Results
finance.yahoo.com - January 10 at 3:18 PM
BD Announces Commencement of Offer to Repurchase its 3.000 ... - PR Newswire (press release)BD Announces Commencement of Offer to Repurchase its 3.000 ... - PR Newswire (press release)
www.prnewswire.com - January 9 at 6:06 AM
BD Announces Commencement of Offer to Repurchase its 3.000% Notes Due 2026BD Announces Commencement of Offer to Repurchase its 3.000% Notes Due 2026
finance.yahoo.com - January 9 at 6:06 AM
KeyCorp Begins Coverage on Becton Dickinson and (BDX)KeyCorp Begins Coverage on Becton Dickinson and (BDX)
www.americanbankingnews.com - January 6 at 10:28 PM
Jefferies Group Comments on Becton Dickinson and Cos FY2022 Earnings (BDX)Jefferies Group Comments on Becton Dickinson and Co's FY2022 Earnings (BDX)
www.americanbankingnews.com - January 5 at 8:24 PM
KeyBanc Initiates Becton, Dickinson And Co. With Bullish StanceKeyBanc Initiates Becton, Dickinson And Co. With Bullish Stance
finance.yahoo.com - January 5 at 3:18 PM
Becton Dickinson and (BDX) Downgraded to Hold at Zacks Investment ResearchBecton Dickinson and (BDX) Downgraded to Hold at Zacks Investment Research
www.americanbankingnews.com - January 5 at 2:32 PM
Becton Dickinson and (BDX) Upgraded by Citigroup to NeutralBecton Dickinson and (BDX) Upgraded by Citigroup to Neutral
www.americanbankingnews.com - January 5 at 10:22 AM
BD to Present at the 36th Annual J. P. Morgan Healthcare ConferenceBD to Present at the 36th Annual J. P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 3:17 PM
Jim Cramer Shares His Thoughts On Hain Celestial, Becton Dickinson And Carnival Corp. - BenzingaJim Cramer Shares His Thoughts On Hain Celestial, Becton Dickinson And Carnival Corp. - Benzinga
www.benzinga.com - January 3 at 11:18 AM
Cramers lightning round: Buy Becton Dickinsons stock hand over fistCramer's lightning round: Buy Becton Dickinson's stock hand over fist
www.cnbc.com - January 2 at 8:18 PM
Becton Dickinson (BDX) Completes CR Bard (BCR) Acquisition - StreetInsider.comBecton Dickinson (BDX) Completes CR Bard (BCR) Acquisition - StreetInsider.com
www.streetinsider.com - December 31 at 3:18 PM
 Analysts Anticipate Becton Dickinson and Co (BDX) Will Post Quarterly Sales of $3.05 Billion Analysts Anticipate Becton Dickinson and Co (BDX) Will Post Quarterly Sales of $3.05 Billion
www.americanbankingnews.com - December 30 at 8:14 AM
Becton Dickinson (BDX) Completes CR Bard (BCR) Acqusition - StreetInsider.comBecton Dickinson (BDX) Completes CR Bard (BCR) Acqusition - StreetInsider.com
www.streetinsider.com - December 30 at 6:11 AM
BD Gets Final Regulatory Approval for Bard AcquisitionBD Gets Final Regulatory Approval for Bard Acquisition
finance.yahoo.com - December 30 at 6:11 AM
Becton Dickinson (BDX) Announces MOFCOM Clearance for C.R. Bard (BCR) AcquisitionBecton Dickinson (BDX) Announces MOFCOM Clearance for C.R. Bard (BCR) Acquisition
www.streetinsider.com - December 29 at 3:16 PM
BD Announces Expiration and Final Results of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. NotesBD Announces Expiration and Final Results of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
finance.yahoo.com - December 29 at 3:16 PM
Becton Dickinson (BDX) PT Raised to $260 at Deutsche Bank on Final Regulatory Clearance from China for Bard Deal - StreetInsider.comBecton Dickinson (BDX) PT Raised to $260 at Deutsche Bank on Final Regulatory Clearance from China for Bard Deal - StreetInsider.com
www.streetinsider.com - December 29 at 8:49 AM
Becton, Dickinson (BDX), Bard Receive Regulatory Nod in ChinaBecton, Dickinson (BDX), Bard Receive Regulatory Nod in China
finance.yahoo.com - December 29 at 8:49 AM
Was Becton Dickinson and Company’s (NYSE:BDX) Earnings Growth Better Than Industry?Was Becton Dickinson and Company’s (NYSE:BDX) Earnings Growth Better Than Industry?
finance.yahoo.com - December 29 at 8:49 AM
Becton Dickinson and (BDX) PT Set at $260.00 by Deutsche BankBecton Dickinson and (BDX) PT Set at $260.00 by Deutsche Bank
www.americanbankingnews.com - December 29 at 7:20 AM
Becton Dickinsons $24 billion takeover of C R Bard set to close after China nodBecton Dickinson's $24 billion takeover of C R Bard set to close after China nod
finance.yahoo.com - December 28 at 5:06 PM
Becton Dickinsons $24 bln takeover of C R Bard set to close after China nodBecton Dickinson's $24 bln takeover of C R Bard set to close after China nod
finance.yahoo.com - December 28 at 5:06 PM
Zacks: Analysts Anticipate Becton Dickinson and Co (BDX) Will Post Earnings of $2.43 Per ShareZacks: Analysts Anticipate Becton Dickinson and Co (BDX) Will Post Earnings of $2.43 Per Share
www.americanbankingnews.com - December 28 at 9:34 AM
Wired News - The U.S. FTC Conditionally Approves Becton, Dickinson and Co.s Takeover of C.R. BardWired News - The U.S. FTC Conditionally Approves Becton, Dickinson and Co.'s Takeover of C.R. Bard
finance.yahoo.com - December 27 at 9:44 AM
Merit Medical Deserves a Place in Your Portfolio: Heres Why - NasdaqMerit Medical Deserves a Place in Your Portfolio: Here's Why - Nasdaq
www.nasdaq.com - December 26 at 1:32 PM
Becton Dickinson (BDX) Issues Statement on FTC Clearance of Bard (BCR) AcquisitionBecton Dickinson (BDX) Issues Statement on FTC Clearance of Bard (BCR) Acquisition
www.streetinsider.com - December 23 at 1:24 AM
Becton, Dickinson to divest two product lines for C R Bard buy: FTCBecton, Dickinson to divest two product lines for C R Bard buy: FTC
www.reuters.com - December 23 at 1:24 AM
Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : December 22, 2017Becton, Dickinson & Co. breached its 50 day moving average in a Bearish Manner : BDX-US : December 22, 2017
finance.yahoo.com - December 23 at 1:24 AM
Becton, Dickinson to divest two product lines for C R Bard buy -FTCBecton, Dickinson to divest two product lines for C R Bard buy -FTC
finance.yahoo.com - December 22 at 8:23 PM
ETFs with exposure to Becton, Dickinson & Co. : December 18, 2017ETFs with exposure to Becton, Dickinson & Co. : December 18, 2017
finance.yahoo.com - December 18 at 3:16 PM
BRIEF-Becton Dickinson And Co Says CEO Vincent Forlenzas FY 2017 Total Compensation Was $13.1 MlnBRIEF-Becton Dickinson And Co Says CEO Vincent Forlenza's FY 2017 Total Compensation Was $13.1 Mln
www.reuters.com - December 15 at 3:18 PM
The Zacks Analyst Blog Highlights: Morris, EOG Resources, Becton, Dickinson, Sirius XM and ABBThe Zacks Analyst Blog Highlights: Morris, EOG Resources, Becton, Dickinson, Sirius XM and ABB
finance.yahoo.com - December 14 at 3:18 PM
Becton, Dickinson and (BDX) Price Target Increased to $235.00 by Analysts at ArgusBecton, Dickinson and (BDX) Price Target Increased to $235.00 by Analysts at Argus
www.americanbankingnews.com - December 14 at 10:22 AM
Top Research Reports for Phillip Morris, EOG Resources & Becton, DickinsonTop Research Reports for Phillip Morris, EOG Resources & Becton, Dickinson
finance.yahoo.com - December 14 at 5:58 AM
Becton, Dickinson and Company (BDX) Expected to Post Quarterly Sales of $3.05 BillionBecton, Dickinson and Company (BDX) Expected to Post Quarterly Sales of $3.05 Billion
www.americanbankingnews.com - December 13 at 10:24 AM

SEC Filings

Becton Dickinson and (NYSE:BDX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Becton Dickinson and (NYSE:BDX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Becton Dickinson and (NYSE BDX) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.